Center Laboratories, Inc.

Taipei Exchange 4123.TWO

Center Laboratories, Inc. Free Cash Flow Per Share for the year ending December 31, 2023: USD -0.05

Center Laboratories, Inc. Free Cash Flow Per Share is USD -0.05 for the year ending December 31, 2023, a -450.30% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

Center Laboratories, Inc. Free Cash Flow Per Share for the year ending December 31, 2022 was USD -0.01, a 51.78% change year over year.
Center Laboratories, Inc. Free Cash Flow Per Share for the year ending December 31, 2021 was USD -0.02, a -5.01% change year over year.
Center Laboratories, Inc. Free Cash Flow Per Share for the year ending December 31, 2020 was USD -0.02, a 61.95% change year over year.
Center Laboratories, Inc. Free Cash Flow Per Share for the year ending December 31, 2019 was USD -0.05, a 13.84% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

Taipei Exchange: 4123.TWO

Center Laboratories, Inc.

CEO	Ms. Su-Chi Wang
IPO Date	Dec. 31, 2007
Location	Taiwan
Headquarters	No. 3-2, Yuanyuan Street
Employees	182
Sector	Health Care
Industries Pharmaceuticals

Description

Center Laboratories, Inc. engages in the manufacture and trading of various medicines in Taiwan. It engages in the research and development of small molecule drugs; manufacture and sale of pharmaceuticals; development of proteins and antibodies; and pharmaceutical CDMO, medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment fund and venture capital businesses. The company was founded in 1959 and is headquartered in Taipei, Taiwan.

Key trends

Past 5 years